Envestnet Asset Management »

Protagonist Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $575k 13k 45.00
2024-06-30 $470k 14k 34.65
2024-03-31 $323k 11k 28.93

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)

View all positions for Envestnet Asset Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
BlackRock
Vanguard Group
Johnson & Johnson
State Street Corporation
Leucadia National Corporation
BVF
Pacer Advisors
Geode Capital Management
Perceptive Advisors
T. Rowe Price Associates
Kynam Capital Management
Invesco
Goldman Sachs Group

View all funds holding Protagonist Therapeutics